Natco Pharma Launched a Generic Version of Celgene’s Pomalyst in US
Natco Pharma Ltd said on Tuesday, 3 March, that it and its partner Breckenridge Pharmaceutical have introduced Pomalidomide capsules, a generic version of Celgene’s Pomalyst,...
Author : Ali Waghbakriwala
Xduce Technologies Acquires 9% Stake in Dev Information Tech
US-based Xduce Technologies purchased an additional more than 9% ownership share in Dev Information Technology, an IT services company, from promoters through open market transactions....
Stocks Under F&O Ban: Sammaan Capital
Under the futures and options (F&O) segment, one stock was banned from trade on Tuesday, 3 March, by the National Stock Exchange (NSE). The securities...
Mahindra and Mahindra Shares Slump 3% on Exiting Japan Agri-Machinery Business
Shares of Mahindra & Mahindra Limited were trading in the red and 3% lower on 2 March after the company announced that they have decided...
Defence Shares Soar 12% as Tensions Flare in the Middle East
Defence-related stocks, such as Bharat Electronics and Paras Defence and Space Technologies, gained by up to 12% on Monday amid rising tensions between Iran, Israel,...
Larsen and Toubro Slumped 6% Amid US-Israel-Iran War
Shares of Larsen and Toubro Ltd (L&T) fell more than 6% in early trading on Monday, 2 March, following the Iran-Israel-US war that began over...
Stocks Under F&O Ban: Sammaan Capital
Under the futures and options (F&O) segment, one stock was banned from trade on Monday, 2 March, by the National Stock Exchange (NSE). The securities...
Overnight Stock Market Movements: Key Developments
Indian benchmark indices, Sensex and Nifty 50, are likely to open lower on Monday as the escalating overnight Middle East conflict unsettled global investors after...
Glenmark Pharma Shares Gain 1% as Arm Launches Sodium Phosphates Injection
Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% on 27 February after the company’s US subsidiary announced that it will launch...
DEE Development Shares Slump 4% Despite Rs 58 Crore Order
Shares of DEE Development Engineers Ltd slumped 4% on 27 February, following the overall market trajectory, despite the company securing a Rs 58 crore order...